Old name, new purpose: why we’ve gone back to RNID

Translational research

Across the UK, 1 in 5 adults have hearing loss and around 1 in 8 adults live with tinnitus. Despite this, there are not yet any clinically approved treatments or cures. We are determined to change this.

We support translational research – where promising discoveries move from the laboratory into clinical trials. RNID’s translational activity to accelerate the development of safe and effective treatments has four key components:

  • funding
  • consultancy
  • working with partners
  • engaging with patients.

Find out more about how we can help in each of these areas below. You can also email hti@rnid.org.uk for more information.